Compared to the control group, the patients of all types of PAH were characterized by a significantly lower percentage of T cells CD8+CD200R+: CHD-PAH and CTEPH (p < 0.001) and iPAH and CTD-PAH (p < 0.01). The gene discussed is CD8A; the disease is chronic thromboembolic pulmonary hypertension.